Morepen Labs surges 18% in two days. Here's why
In a separate development, a top company official told PTI that the company was betting big on the diagnostics devices segment, while building its presence in the active pharmaceutical ingredient (API) segment. The stock, which surged 9.42 per cent on Wednesday, advanced another 7.7 per cent to hit a high of Rs 59.45 in Thursday’s trade. This took the two-day gain for the stock to 18 per cent. Morepen Laboratories' board approved issue of up to 5.85 crore equity shares to Corinth Investment Holdings AG, a Switzerland-based entity that belongs to the public category. The shared will be issue...